Study Evaluates Population-based Breast Cancer Screening Methods

Study Evaluates Population-based Breast Cancer Screening Methods
Study Evaluates Population-based Breast Cancer Screening Methods

Population-based screening for breast cancer with universal biennial mammography resulted in a substantial reduction in breast cancer deaths, while risk-based biennial mammography resulted in only a modest benefit, compared with annual clinical breast examination, a study published in JAMA Oncology has shown.1

Although a variety of screening strategies for breast cancer are available, they have not been evaluated in a population-based study. Therefore, researchers sought to assess the benefits and harms of risk-based and universal mammography screening in comparison with annual clinical breast examination.

For the population-based cohort study, researchers enrolled 1 429 890 asymptomatic women attending outreach screening in the community or undergoing mammography in hospitals into 1 of the 3 screening programs.

Results showed that detection rates were the highest for universal biennial mammography, followed by risk-based mammography, and were lowest for annual clinical breast examination.

Researchers found that compared with annual clinical breast examination, universal biennial mammography screening was associated with a 41% reduction in death and a 30% reduction in the incidence of stage 2+ breast cancer.

Risk-based mammography screening was associated with an 8% reduction of stage 2+ breast cancer; however, this screening method was not associated with a significant reduction in mortality.

In terms of overdiagnosis, annual clinical breast examination and risk-based mammography screening had similar rates, while universal mammography had a 13% higher rate of overdiagnosis.

REFERENCE

1. Yen AM, Tsau HS, Fann JC, et al. Population-based breast cancer screening with risk-based and universal mammography screening compared with clinical breast examination [published online ahead of print March 31, 2016]. JAMA Oncol. doi:10.1001/jamaoncol.2016.0447.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs